Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2025-12-28 @ 2:30 PM
Study NCT ID:
NCT04797468
Status:
WITHDRAWN
Last Update Posted:
2023-01-17
First Post:
2021-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-04
First Submit QC Date:
None
Study First Post Date:
2021-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-13
Last Update Post Date:
2023-01-17
Last Update Post Date Type:
ACTUAL